患有系统性自身免疫性炎症疾病的患者心力衰竭风险
Alexia A Zagouras1, Pieter Martens2, W H Wilson Tang3
1Department of Internal Medicine Stanford University School of Medicine Stanford CA USA.
Journal of the American Heart Association
|January 14, 2026
概括
患有全身性自身免疫性炎症性疾病 (SAID) 的患者,如全身性硬化症,狼和类风湿性关节炎,面临更高的心力衰竭 (HF) 风险. 在这些患者中,β-阻断剂的使用可能会提供对HF的保护.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性自身免疫性炎症性疾病 (SAIDs) 显著增加了由于心脏病,特别是心力衰竭 (HF) 的发病率和死亡率.
- 了解SAID患者的HF风险和心血管药物的影响对于改善患者的治疗结果至关重要.
研究的目的:
- 评估各种系统性自身免疫性炎症性疾病 (SAID) 患者发生心力衰竭 (HF) 的风险.
- 调查心血管药物使用与SAID患者中HF事件发生之间的关联.
主要方法:
- 一项回顾性队列研究分析了2000年至2020年182,795名患有SAIDs (包括全身性硬化症,狼,类风湿性关节炎,牛皮关节炎,炎症性肠病和艾滋病毒) 的成年患者的电子健康记录.
- 在一个大型医疗保健系统内追踪了发生性HF风险,将SAID患者与对照者进行比较,并分析药物效应.
主要成果:
- 系统性硬化症,系统性红斑狼和类风湿性关节炎与对照组和炎症性肠病患者相比,与发生HF风险的增加有显著关联.
- 在基线时使用β-阻断剂表明,在患有全身性硬化症,狼和类风湿性关节炎的患者中,HF发生率降低的相关性.
结论:
- 患有全身性硬化症,狼和类风湿性关节炎的患者表现出高心血管风险,这表明自身免疫机制有助于心脏参与.
- 贝塔抑制剂的使用似乎具有心脏保护作用,可能减少SAID患者的HF发病率.
相关概念视频
01:23Rheumatic Heart Disease I: Introduction
426
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426
01:20Rheumatic Heart Disease IV: Nursing Management
264
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
264
01:17Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
476
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476
01:27Heart Failure I: Introduction
678
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
678
01:29Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707